1 Market Overview of Beta-Lactam Drugs 1.1 Beta-Lactam Drugs Market Overview 1.1.1 Beta-Lactam Drugs Product Scope 1.1.2 Beta-Lactam Drugs Market Status and Outlook 1.2 Global Beta-Lactam Drugs Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Beta-Lactam Drugs Market Size by Region (2016-2027) 1.4 Global Beta-Lactam Drugs Historic Market Size by Region (2016-2021) 1.5 Global Beta-Lactam Drugs Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Beta-Lactam Drugs Market Size (2016-2027) 1.6.1 North America Beta-Lactam Drugs Market Size (2016-2027) 1.6.2 Europe Beta-Lactam Drugs Market Size (2016-2027) 1.6.3 Asia-Pacific Beta-Lactam Drugs Market Size (2016-2027) 1.6.4 Latin America Beta-Lactam Drugs Market Size (2016-2027) 1.6.5 Middle East & Africa Beta-Lactam Drugs Market Size (2016-2027) 2 Beta-Lactam Drugs Market Overview by Type 2.1 Global Beta-Lactam Drugs Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Beta-Lactam Drugs Historic Market Size by Type (2016-2021) 2.3 Global Beta-Lactam Drugs Forecasted Market Size by Type (2022-2027) 2.4 Penicillin 2.5 Cephalosporins 2.6 Carbapenem 2.7 Monobacteria 3 Beta-Lactam Drugs Market Overview by Application 3.1 Global Beta-Lactam Drugs Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Beta-Lactam Drugs Historic Market Size by Application (2016-2021) 3.3 Global Beta-Lactam Drugs Forecasted Market Size by Application (2022-2027) 3.4 Hospital Pharmacies 3.5 Retail Pharmacies 3.6 Online Pharmacies 4 Beta-Lactam Drugs Competition Analysis by Players 4.1 Global Beta-Lactam Drugs Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2020) 4.3 Date of Key Players Enter into Beta-Lactam Drugs Market 4.4 Global Top Players Beta-Lactam Drugs Headquarters and Area Served 4.5 Key Players Beta-Lactam Drugs Product Solution and Service 4.6 Competitive Status 4.6.1 Beta-Lactam Drugs Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 GlaxoSmithKline plc 5.1.1 GlaxoSmithKline plc Profile 5.1.2 GlaxoSmithKline plc Main Business 5.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Products, Services and Solutions 5.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Revenue (US$ Million) & (2016-2021) 5.1.5 GlaxoSmithKline plc Recent Developments 5.2 Pfizer, Inc. 5.2.1 Pfizer, Inc. Profile 5.2.2 Pfizer, Inc. Main Business 5.2.3 Pfizer, Inc. Beta-Lactam Drugs Products, Services and Solutions 5.2.4 Pfizer, Inc. Beta-Lactam Drugs Revenue (US$ Million) & (2016-2021) 5.2.5 Pfizer, Inc. Recent Developments 5.3 AstraZeneca plc 5.5.1 AstraZeneca plc Profile 5.3.2 AstraZeneca plc Main Business 5.3.3 AstraZeneca plc Beta-Lactam Drugs Products, Services and Solutions 5.3.4 AstraZeneca plc Beta-Lactam Drugs Revenue (US$ Million) & (2016-2021) 5.3.5 Merck & Co., Inc. Recent Developments 5.4 Merck & Co., Inc. 5.4.1 Merck & Co., Inc. Profile 5.4.2 Merck & Co., Inc. Main Business 5.4.3 Merck & Co., Inc. Beta-Lactam Drugs Products, Services and Solutions 5.4.4 Merck & Co., Inc. Beta-Lactam Drugs Revenue (US$ Million) & (2016-2021) 5.4.5 Merck & Co., Inc. Recent Developments 5.5 Eli Lilly and Company 5.5.1 Eli Lilly and Company Profile 5.5.2 Eli Lilly and Company Main Business 5.5.3 Eli Lilly and Company Beta-Lactam Drugs Products, Services and Solutions 5.5.4 Eli Lilly and Company Beta-Lactam Drugs Revenue (US$ Million) & (2016-2021) 5.5.5 Eli Lilly and Company Recent Developments 5.6 Shionogi & Co., Ltd. 5.6.1 Shionogi & Co., Ltd. Profile 5.6.2 Shionogi & Co., Ltd. Main Business 5.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Products, Services and Solutions 5.6.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue (US$ Million) & (2016-2021) 5.6.5 Shionogi & Co., Ltd. Recent Developments ... 6 North America 6.1 North America Beta-Lactam Drugs Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Beta-Lactam Drugs Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Beta-Lactam Drugs Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Beta-Lactam Drugs Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Beta-Lactam Drugs Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Beta-Lactam Drugs Market Dynamics 11.1 Beta-Lactam Drugs Industry Trends 11.2 Beta-Lactam Drugs Market Drivers 11.3 Beta-Lactam Drugs Market Challenges 11.4 Beta-Lactam Drugs Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Beta-Lactam Drugs Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Beta-Lactam Drugs Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Beta-Lactam Drugs Market Size Share by Region (2016-2021) Table 4. Global Beta-Lactam Drugs Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Beta-Lactam Drugs Forecasted Market Size Share by Region (2022-2027) Table 6. Global Beta-Lactam Drugs Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Beta-Lactam Drugs Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Beta-Lactam Drugs Revenue Market Share by Type (2016-2021) Table 9. Global Beta-Lactam Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Beta-Lactam Drugs Revenue Market Share by Type (2022-2027) Table 11. Global Beta-Lactam Drugs Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Beta-Lactam Drugs Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Beta-Lactam Drugs Revenue Market Share by Application (2016-2021) Table 14. Global Beta-Lactam Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Beta-Lactam Drugs Revenue Market Share by Application (2022-2027) Table 16. Global Beta-Lactam Drugs Revenue (US$ Million) by Players (2016-2021) Table 17. Global Beta-Lactam Drugs Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2020) Table 19. Date of Key Manufacturers Enter into Beta-Lactam Drugs Market Table 20. Global Beta-Lactam Drugs Top Players Headquarters and Area Served Table 21. Beta-Lactam Drugs Product Solution and Service Table 22. Global Beta-Lactam Drugs Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. GlaxoSmithKline plc Basic Information List Table 25. GlaxoSmithKline plc Description and Business Overview Table 26. GlaxoSmithKline plc Beta-Lactam Drugs Products, Services and Solutions Table 27. Revenue (US$ Million) in Beta-Lactam Drugs Business of GlaxoSmithKline plc (2016-2021) Table 28. GlaxoSmithKline plc Recent Developments Table 29. Pfizer, Inc. Basic Information List Table 30. Pfizer, Inc. Description and Business Overview Table 31. Pfizer, Inc. Beta-Lactam Drugs Products, Services and Solutions Table 32. Revenue (US$ Million) in Beta-Lactam Drugs Business of Pfizer, Inc. (2016-2021) Table 33. Pfizer, Inc. Recent Developments Table 34. AstraZeneca plc Basic Information List Table 35. AstraZeneca plc Description and Business Overview Table 36. AstraZeneca plc Beta-Lactam Drugs Products, Services and Solutions Table 37. Revenue (US$ Million) in Beta-Lactam Drugs Business of AstraZeneca plc (2016-2021) Table 38. AstraZeneca plc Recent Developments Table 39. Merck & Co., Inc. Basic Information List Table 40. Merck & Co., Inc. Description and Business Overview Table 41. Merck & Co., Inc. Beta-Lactam Drugs Products, Services and Solutions Table 42. Revenue (US$ Million) in Beta-Lactam Drugs Business of Merck & Co., Inc. (2016-2021) Table 43. Merck & Co., Inc. Recent Developments Table 44. Eli Lilly and Company Basic Information List Table 45. Eli Lilly and Company Description and Business Overview Table 46. Eli Lilly and Company Beta-Lactam Drugs Products, Services and Solutions Table 47. Revenue (US$ Million) in Beta-Lactam Drugs Business of Eli Lilly and Company (2016-2021) Table 48. Eli Lilly and Company Recent Developments Table 49. Shionogi & Co., Ltd. Basic Information List Table 50. Shionogi & Co., Ltd. Description and Business Overview Table 51. Shionogi & Co., Ltd. Beta-Lactam Drugs Products, Services and Solutions Table 52. Revenue (US$ Million) in Beta-Lactam Drugs Business of Shionogi & Co., Ltd. (2016-2021) Table 53. Shionogi & Co., Ltd. Recent Developments Table 54. North America Beta-Lactam Drugs Market Size by Country (2016-2021) & (US$ Million) Table 55. North America Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million) Table 56. Europe Beta-Lactam Drugs Market Size by Country (2016-2021) & (US$ Million) Table 57. Europe Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million) Table 58. Asia-Pacific Beta-Lactam Drugs Market Size by Region (2016-2021) & (US$ Million) Table 59. Asia-Pacific Beta-Lactam Drugs Market Size by Region (2022-2027) & (US$ Million) Table 60. Asia-Pacific Beta-Lactam Drugs Market Share by Region (2016-2021) Table 61. Asia-Pacific Beta-Lactam Drugs Market Share by Region (2022-2027) Table 62. Latin America Beta-Lactam Drugs Market Size by Country (2016-2021) & (US$ Million) Table 63. Latin America Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million) Table 64. Middle East & Africa Beta-Lactam Drugs Market Size by Players (2016-2021) & (US$ Million) Table 65. Middle East & Africa Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million) Table 66. Beta-Lactam Drugs Market Trends Table 67. Beta-Lactam Drugs Market Drivers Table 68. Beta-Lactam Drugs Market Challenges Table 69. Beta-Lactam Drugs Market Restraints Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Global Beta-Lactam Drugs Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Beta-Lactam Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Beta-Lactam Drugs Market Share by Regions: 2021 VS 2027 Figure 4. Global Beta-Lactam Drugs Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Beta-Lactam Drugs Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Beta-Lactam Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Beta-Lactam Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Beta-Lactam Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Beta-Lactam Drugs Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Beta-Lactam Drugs Market Size Share by Type in 2021 & 2027 Figure 11. Penicillin Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Cephalosporins Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Carbapenem Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Monobacteria Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Beta-Lactam Drugs Market Size Share by Application in 2021 & 2027 Figure 16. Hospital Pharmacies Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Retail Pharmacies Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Online Pharmacies Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Beta-Lactam Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Top 5 and Top 10 Players Beta-Lactam Drugs Market Share in 2020 Figure 21. North America Beta-Lactam Drugs Market Share by Country (2016-2027) Figure 22. United States Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 23. Canada Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 24. Germany Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 25. France Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 26. U.K. Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 27. Italy Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 28. Russia Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 29. Nordic Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 30. Rest of Europe Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 31. Asia-Pacific Beta-Lactam Drugs Market Share by Region (2016-2027) Figure 32. China Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 33. Japan Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 34. South Korea Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 35. Southeast Asia Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 36. India Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 37. Australia Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 38. Rest of Asia-Pacific Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 39. Latin America Beta-Lactam Drugs Market Share by Country (2016-2027) Figure 40. Mexico Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 41. Brazil Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 42. Rest of Latin America Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 43. Middle East & Africa Beta-Lactam Drugs Market Share by Country (2016-2027) Figure 44. Turkey Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 45. Saudi Arabia Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 46. UAE Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 47. Rest of Middle East & Africa Beta-Lactam Drugs Market Size (2016-2027) & (US$ Million) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation

GlaxoSmithKline plc Pfizer, Inc. AstraZeneca plc Merck & Co., Inc. Eli Lilly and Company Shionogi & Co., Ltd.